Skip to main content
. Author manuscript; available in PMC: 2021 Apr 14.
Published in final edited form as: Health Aff (Millwood). 2021 Mar 11;40(4):655–663. doi: 10.1377/hlthaff.2020.02191

EXHIBIT 1.

Characteristics of residents with COVID-19 in a sample of US nursing homes, March 16-November 15, 2020

Characteristics Number/median/
meana
Percent/
IQR/SDb

Median age, years (IQR) 79 69–88

Age, years
 Less than 65 1,916 16
 65–69 1,239 10
 70–74 1,538 13
 75–79 1,611 13
 80–84 1,726 14
 85–89 1,814 15
 90 or older 2,304 19

Female sex 7,538 61

Race
 White 8,586 70
 Black 1,978 16
 Other 1,707 14

Mean ADL score (SD)c 16.7 6.2

ADL dependency score quartile
 0–13 3,069 25
 14–18 3,057 25
 20–21 2,766 23
 22–28 3,379 28

CFS score
 1 4,761 39
 2 2,796 23
 3 3,558 29
 4 1,064 9

Postacute patient 1,631 13

Chronic conditions
 Dementia 5,599 46
 Heart failure 2,691 22
 Coronary artery disease 2,816 23
 COPD or asthmad 2,987 24
 Chronic kidney diseasee 3,155 26
 Hypertension 9,526 78
 Diabetes 4,775 39

Symptoms at presentation
 Any symptomf 5,645 46
 Fever 2,936 24
 Tachycardia 959 8
 Hypoxia 974 8
 Shortness of breath 567 5

SOURCE Authors’ analysis of resident-level data from 282 nursing homes operated by a large long-term care provider.

NOTES N = 12,271 residents. IQR is interquartile range. SD is standard deviation. ADL is activities of daily living. CFS is Cognitive Function Scale. COPD is chronic obstructive pulmonary disease.

a

Number unless otherwise indicated.

b

Percent unless otherwise indicated.

c

Range: 0–28.

d

Classified in the Minimum Data Set as “asthma, chronic obstructive pulmonary disease, chronic bronchitis, and restrictive lung diseases.”

e

Classified in the Minimum Data Set as "renal insufficiency, renal disease, or end-stage renal disease."

f

Residents were classified as symptomatic if any of the following symptoms were present during the five days before their first positive test or during the fourteen days afterward: cough, sore throat, nasal congestion, rhinorrhea, fever, shortness of breath, chest congestion, nausea, vomiting, diarrhea, anosmia, malaise, confusion, tachycardia, and hypoxia. See the Study Data And Methods section for further details.